Annual report [Section 13 and 15(d), not S-K Item 405]

Discontinued Operations (Tables)

v3.25.1
Discontinued Operations (Tables)
12 Months Ended
Dec. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Components of Assets and Liabilities and Revenue Classified as Discontinued

The table below presents the significant components of its former Pharma Solutions and Commercial Services business units’ results included within loss from discontinued operations, net of tax in the consolidated statements of operations for the years ended December 31, 2024 and 2023.

 

    2024     2023  
    For The Years Ended  
    December 31,  
    2024     2023  
          (as restated)  
Revenue, net   $ -     $ -  
                 
Loss from discontinued operations     -       (43 )
Income tax expense     244       267  
Loss from discontinued operations, net of tax   $ (244 )   $ (310 )